Impact of HMGB1, RAGE, and TLR4 in Alzheimer’s Disease (AD): From Risk Factors to Therapeutic Targeting
Alzheimer’s disease (AD) is a devastating neurodegenerative disorder and a leading cause of dementia, with accumulation of amyloid-beta (Aβ) and neurofibrillary tangles (NFTs) as defining pathological features. AD presents a serious global health concern with no cure to date, refl...
Main Authors: | Yam Nath Paudel, Efthalia Angelopoulou, Christina Piperi, Iekhsan Othman, Khurram Aamir, Mohd. Farooq Shaikh |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-02-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/9/2/383 |
Similar Items
-
HMGB1-Mediated Neuroinflammatory Responses in Brain Injuries: Potential Mechanisms and Therapeutic Opportunities
by: Yam Nath Paudel, et al.
Published: (2020-06-01) -
HMGB1/RAGE axis in tumor development: unraveling its significance
by: Anqi Fan, et al.
Published: (2024-03-01) -
Spinal HMGB1 participates in the early stages of paclitaxel-induced neuropathic pain via microglial TLR4 and RAGE activation
by: Thamyris Reis Moraes, et al.
Published: (2024-02-01) -
HMGB1 in inflammation and cancer
by: Shumin Wang, et al.
Published: (2020-08-01) -
The role of HMGB1/RAGE/TLR4 signaling pathways in cigarette smoke‐induced inflammation in chronic obstructive pulmonary disease
by: Ling Lin, et al.
Published: (2022-11-01)